J0833 — Injection, cosyntropin, not otherwise specified, 0.25 mg
J0833 is a HCPCS Level II code for injection, cosyntropin, not otherwise specified, 0.25 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2018 and is not valid on new claims.
This code has been terminated
CMS terminated J0833 on December 31, 2018. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J0833
- Long descriptor
- Injection, cosyntropin, not otherwise specified, 0.25 mg
- Short descriptor
- Cosyntropin injection nos
- Added
- January 1, 2010
- Terminated
- December 31, 2018
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J0833
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J0833 is not quite right, the correct code is very often within a few positions of it.
- J0775Injection, collagenase, clostridium histolyticum, 0.01 mg
- J0780Injection, prochlorperazine, up to 10 mg
- J0791Injection, crizanlizumab-tmca, 5 mg
- J0795Injection, corticorelin ovine triflutate, 1 microgramterminated
- J0799Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified
- J0800Injection, corticotropin, up to 40 unitsterminated
- J0801Injection, corticotropin (acthar gel), up to 40 units
- J0802Injection, corticotropin (ani), up to 40 units
- J0834Injection, cosyntropin, 0.25 mg
- J0840Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram
- J0841Injection, crotalidae immune f(ab')2 (equine), 120 mg
- J0850Injection, cytomegalovirus immune globulin intravenous (human), per vial
- J0870Injection, imetelstat, 1 mg
- J0872Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg
- J0873Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg
- J0874Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg
Questions about J0833
What is HCPCS code J0833?
J0833 is a HCPCS Level II code for injection, cosyntropin, not otherwise specified, 0.25 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J0833?
The CMS HCPCS file marks J0833 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
Is J0833 still valid?
No. J0833 was terminated on December 31, 2018 and should not be used on new claims.